Price data is not available
EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc.
EFTROTCEM
EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc. (EFTR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.16 | $-1.65 | $-3.00 | $-5.00 |
| Actual | $-2.16 | $-3.42 | $-3.25 | $-4.25 |
| Surprise | 0.00% | -107.3% | -8.33% | +15.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 9, 2024 | $-2.16 | $-2.16 | 0.00 % |
| Q4 | Mar 25, 2024 | $-3.42 | $-1.65 | -107.3 % |
| Q3 | Nov 13, 2023 | $-3.25 | $-3.00 | -8.33 % |
| Q2 | Aug 8, 2023 | $-4.25 | $-5.00 | 15.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 8, 2023 | $674.00K | $660.00K | 2.12 % |
| Q3 | Nov 7, 2022 | $867.00K | $640.00K | 35.5 % |
| Q2 | Aug 9, 2022 | $2.01M | $520.00K | 286.7 % |
| Q1 | May 10, 2022 | $0 | $350.00K | -100.0 % |
